Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

September 6, 2017

Primary Completion Date

December 1, 2022

Study Completion Date

June 30, 2023

Conditions
Pancreas CancerCancer
Interventions
DEVICE

CivaSheet

The FDA Cleared CivaSheet Directional Pd103 Brachytherapy Source is a planar radiation source which utilizes gold shielding in its construction. This device is radioactive on one side only, and is capable of safely delivering high doses of radiation to target areas even when placed directly adjacent to sensitive, healthy tissue or critical structures.

Trial Locations (1)

27834

East Carolina University, Brody School of Medicine, Greenville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CivaTech Oncology

INDUSTRY